DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO… Read More
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO… Read More
Armed with More Accurate Information on the True Impact of Pharma-Backed… Read More
ORPHAN Cures Act Will Enable Big Pharma to Keep Drug Prices High on Top Money… Read More
Big Pharma Company Beats Wall Street Expectations Following Price Hikes on… Read More
Senate Judiciary Lawmakers Should Reject Big Pharma-Backed Proposal and… Read More
PhRMA Continues to Dodge Responsibility for Egregious Pricing Practices and… Read More
U.S. House Committee on Energy and Commerce Advances Bipartisan… Read More
Analysis Finds Brand Name Drug Companies Declined to Even Attempt a Defense of… Read More
Makary Highlights and Adds to Momentum “Across the Political Spectrum” to… Read More
Lawmakers Should Advance Bipartisan, Market-Based Solution to Crack Down on… Read More
Report Underscores How Competition Lowers Prescription Drug Prices by… Read More
Patent Abuse Blocked Competition From More Affordable Alternatives For Periods… Read More